Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical phenotype of colorectal carcinoma in patients with KRAS mutation and mismatch repair status.

Folia medica - 30 Jun 2023

Tashkova Desislava, Ilieva Nevena, Serteva Denitsa, Feodorova Yana, Mehterov Nikolay, Mollova Angelina, Bachurska Svitlana

Abstract excerpt

INTRODUCTION: Aberrant expression of CK7/CK20/CDX2 is reported in percentage of colorectal carcinomas (CRC).

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Colorectal Neoplasms
Share to DNA Mismatch Repair

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Phenotype

Share to Proto-Oncogene Proteins p21(ras)

Source

Identifiers

PMID: 38351812
DOI: 10.3897/folmed.65.e81334

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical phenotype of colorectal carcinoma in patients with KRAS mutation and mismatch repair status.PMID 38351812Read ↗

Immunohistochemistry staining for the mismatch repair proteins in the clinical care of patients with colorectal cancerSemantic proximity Read ↗

Molecular genetic analysis of colorectal carcinoma with an aggressive extraintestinal immunohistochemical phenotype.Semantic proximity Read ↗

BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.Semantic proximity Read ↗

Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressive behavior in colorectal cancerSemantic proximity Read ↗

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestineSemantic proximity Read ↗

Comprehensive clinicopathologic, molecular, and immunologic characterization of colorectal carcinomas with loss of three intestinal markers, CDX2, SATB2, and KRT20.Semantic proximity Read ↗

Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinomaSemantic proximity Read ↗

DNA mismatch repair protein immunohistochemistry - an illustrated guide.Semantic proximity Read ↗

Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.Semantic proximity Read ↗

Two-stain immunohistochemical screening for Lynch syndrome in colorectal cancer may fail to detect mismatch repair deficiencySemantic proximity Read ↗

CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2Semantic proximity Read ↗

Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.